0000950123-21-014094.txt : 20211105
0000950123-21-014094.hdr.sgml : 20211105
20211105165248
ACCESSION NUMBER: 0000950123-21-014094
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210930
FILED AS OF DATE: 20211105
DATE AS OF CHANGE: 20211105
EFFECTIVENESS DATE: 20211105
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRV GP III, LLC
CENTRAL INDEX KEY: 0001637299
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18417
FILM NUMBER: 211385312
BUSINESS ADDRESS:
STREET 1: THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617)585-2000
MAIL ADDRESS:
STREET 1: THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001637299
XXXXXXXX
09-30-2021
09-30-2021
false
TRV GP III, LLC
Third Rock Ventures
29 Newbury Street, 3rd Floor
Boston
MA
02116
13F HOLDINGS REPORT
028-18417
N
Kevin Gillis
Chief Operating Officer
617-585-2000
/s/ Kevin Gillis
Boston
MA
11-05-2021
3
7
526763
false
1
028-18439
Mark Levin
2
028-18438
Kevin P. Starr
3
028-18419
Robert I. Tepper
INFORMATION TABLE
2
6754.xml
INFORMATION TABLE FOR FORM 13F
DECIBEL THERAPEUTICS, INC.
COM
24343R106
24207
3139685
SH
DFND
1,2,3
3139685
0
0
FULCRUM THERAPEUTICS, INC.
COM
359616109
139984
4962202
SH
DFND
1,2,3
4962202
0
0
JOUNCE THERAPEUTICS, INC.
COM
481116101
22652
3048780
SH
DFND
1,2,3
3048780
0
0
NURIX THERAPEUTICS, INC.
COM
67080M103
72580
2422549
SH
DFND
1,2,3
2422549
0
0
PLIANT THERAPEUTICS, INC.
COM
729139105
98565
5839160
SH
DFND
1,2,3
5839160
0
0
REVOLUTION MEDICINES, INC.
COM
76155X100
151966
5524031
SH
DFND
1,2,3
5524031
0
0
VOYAGER THERAPEUTICS, INC.
COM
92915B106
16809
6391176
SH
DFND
1,2,3
6391176
0
0